1 Min Read
* Says it plans to divest biosimilar and medicine business into new subsidiary
* Divestiture effective date is April 30
Source text in Korean: goo.gl/UDEyis
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.